Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

about

Exogenous Nitric Oxide Protects Human Embryonic Stem Cell-Derived Cardiomyocytes against Ischemia/Reperfusion Injury Models of Ischemia-Reperfusion Injury

P2860

Q37049458-F4EF90F3-3CC0-4CDB-B968-F43FD2041B2E Q58561894-95EFE047-2776-4091-B11F-64799402973E

P2860

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

Item

http://www.wikidata.org/entity/Q51018244

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@en

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@nl

type

Item

label

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@en

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@nl

prefLabel

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@en

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@nl

P1476

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

@en

P2093

Anne Hsieh

http://www.w3.org/2001/XMLSchema#string

Milica Radisic

http://www.w3.org/2001/XMLSchema#string

Nicole T Feric

http://www.w3.org/2001/XMLSchema#string

P2860

Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction

Mechanisms of nitrite bioactivation

Medium perfusion enables engineering of compact and contractile cardiac tissue

Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population

Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines

Cell therapy for cardiac repair--lessons from clinical trials.

Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI)

Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver

Ischemic preconditioning in isolated cells.

Regulation of myoglobin expression

P304

482-492

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BTPR.2039

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25582867

http://www.w3.org/2001/XMLSchema#string

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

about

P2860

P2860

Combined hypoxia and sodium nitrite pretreatment for cardiomyocyte protection in vitro.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698